Skip to main content
Premium Trial:

Request an Annual Quote

Tokyo Pharma Licenses Rosetta's Biomarker Software

NEW YORK (GenomeWeb News) - Japanese pharmaceutical company Eisai has licensed Rosetta Biosoftware's Elucidator protein expression and biomarker discovery system, Rosetta said yesterday.
 
Seattle-based Rosetta said Eisai plans to use the Elucidator system to support LC/MS methods for biomarker research in neurology at the Laboratory of Seeds Finding Technology
 
Elucidator enables data management and analysis workflow for comparative proteomics, Rosetta said.
 
Financial terms of the deal were not released.

The Scan

Myotonic Dystrophy Repeat Detected in Family Genome Sequencing Analysis

While sequencing individuals from a multi-generation family, researchers identified a myotonic dystrophy type 2-related short tandem repeat in the European Journal of Human Genetics.

TB Resistance Insights Gleaned From Genome Sequence, Antimicrobial Response Assays

Researchers in PLOS Biology explore M. tuberculosis resistance with a combination of sequencing and assays looking at the minimum inhibitory concentrations of 13 drugs.

Mendelian Disease Genes Prioritized Using Tissue-Specific Expression Clues

Mendelian gene candidates could be flagged for further functional analyses based on tissue-specific transcriptome and proteome profiles, a new Journal of Human Genetics paper says.

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.